Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.
about
The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and TreatmentThe Role of Chemokines in Promoting Colorectal Cancer Invasion/MetastasisMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentVascular normalization and cancer immunotherapyMyeloid-derived suppressor cells as therapeutic target in hematological malignanciesMyeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implicationsRegulation of tumor metastasis by myeloid-derived suppressor cellsThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionImmunosuppression associated with chronic inflammation in the tumor microenvironmentMDSCs mediate angiogenesis and predispose canine mammary tumor cells for metastasis via IL-28/IL-28RA (IFN-λ) signaling.Molecular pathways: myeloid complicity in cancer.Tumor-induced myeloid dysfunction and its implications for cancer immunotherapyTumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.Complexity and challenges in defining myeloid-derived suppressor cellsMyeloid derived suppressor cells in chronic myeloid leukemia.Increased CD160 expression on circulating natural killer cells in atherogenesis.Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancerProgressive loss of anti-HER2 CD4(+) T-helper type 1 response in breast tumorigenesis and the potential for immune restorationImmunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives.Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body RadiotherapyNeural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer.An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells.Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and ExtentActivated T cells sustain myeloid-derived suppressor cell-mediated immune suppression.Contributions of neutrophils to the adaptive immune response in autoimmune disease.CD39 and CD73 in immunity and inflammation.Identification of CD4(+)CD25(+)CD127(-) regulatory T cells and CD14(+)HLA(-)DR(-)/low myeloid-derived suppressor cells and their roles in the prognosis of breast cancerReduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observationsIncreased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer PatientsMyeloid-derived suppressor cells in cancer: recent progress and prospects.Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature.Clinical evaluation of systemic and local immune responses in cancer: time for integration.Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.Myeloid-derived suppressor cell heterogeneity in human cancers.Overcoming tumor-mediated immunosuppression.Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.Impact of the immune system and immunotherapy in colorectal cancer.Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer.Myeloid-derived suppressor cells in gastrointestinal cancers: A systematic review.The Role of Myeloid-Derived Suppressor Cells in Viral Infection.
P2860
Q26745580-B77D7D10-962F-495D-9D8C-B37DEF482C6FQ26748194-710E8863-43CB-4089-A5D0-30E4DC23EBECQ26799126-EC577EC2-A99C-44E1-9E3C-A2B9132A87ECQ26827437-FF2E8031-C69D-46D9-8767-97BA6EE0D5BFQ27010234-975A5192-F40F-4C53-9019-DEF68F07AFE5Q27014189-6C78DE21-587C-421D-ABF5-A8555F6F82BCQ27022125-2F3F5811-045C-4131-9AC6-A8CE3AA37919Q28076760-4B615A2A-6C7D-4BEA-9AC7-C34612FE9383Q28083450-6B92B4BA-BEC9-4DEE-9B7D-9AAEB66D28C3Q33975551-87A6ACEB-4790-4713-9219-F593198700B0Q34725969-98203F62-9C47-4741-9FA6-3C94D78FF518Q34810257-748A7535-B815-4E86-B1EB-3647955D88B6Q35169807-DA400FA0-3CCB-4EE0-B4DD-401C0D3F484FQ35509317-7A8912B4-20EE-42FA-B3B6-D05CD4E22DADQ35609094-E34361AD-7CAC-41FE-A7D6-1CB688CFCC31Q35743284-E1397339-F3DB-4890-A1C7-A64046B0BC4CQ35828574-3DB9C9CF-DC3E-445C-BBA5-712F022D3353Q36107949-6B3534B3-03C2-4F16-A90D-95415AA607BAQ36114649-E74BF18B-88A7-426C-896D-E5AAF75506D9Q36483105-879A990D-067E-43E1-846F-E58E196BD1BBQ36549023-7EE72040-5711-463B-96CE-06BACE1EA7A6Q36632163-A8FD20C2-4616-4EB9-B844-7E37E91D5F60Q36683267-573F95E7-62A1-4B0B-BF6A-906C45845760Q36738775-0E3B56DA-C934-4C63-8F6B-A5DB24E19137Q36751862-22AA833F-A815-4CD9-97DD-BE1E20E6B703Q36906658-3FB25004-9C36-4B5D-9144-97794C85F2ACQ37108235-BF77B0A0-AA79-4EBB-AA45-C8B94755F140Q37205878-6C30F2FF-4B5D-45A0-908C-4CBD1D8ECCC7Q37483023-0EDF6252-0B27-4C6D-B5E2-975199A25D87Q38116711-7C0BD4F7-3519-4E35-896D-97B17DE76C2CQ38132055-6C064466-B136-4926-ADF5-A6BA649DEB6FQ38150174-F43FCC38-1705-4570-B365-60FE2B303A0CQ38185156-FAD6E92D-FB91-46B7-A9F0-0DBF4B2F2BAFQ38223250-245E93F5-D73F-4D50-807F-B8CB4DC0F7F5Q38262255-F29DC176-D025-4575-9ACD-159206D09FE9Q38299932-186BED9E-F3DD-402C-87AD-6894DC02ACE1Q38398877-0B2D8D25-2B95-439F-8573-9F5080781A38Q38528814-310E91F9-BC2A-493C-8814-34E347413CF6Q38686288-81C34ED5-5368-4132-A25C-42A20746ACD5Q38774994-1635B263-3888-4CA5-BB01-6E28B1D677F3
P2860
Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Circulating and tumor-infiltra ...... nts with colorectal carcinoma.
@ast
Circulating and tumor-infiltra ...... nts with colorectal carcinoma.
@en
Circulating and tumor-infiltra ...... nts with colorectal carcinoma.
@nl
type
label
Circulating and tumor-infiltra ...... nts with colorectal carcinoma.
@ast
Circulating and tumor-infiltra ...... nts with colorectal carcinoma.
@en
Circulating and tumor-infiltra ...... nts with colorectal carcinoma.
@nl
prefLabel
Circulating and tumor-infiltra ...... nts with colorectal carcinoma.
@ast
Circulating and tumor-infiltra ...... nts with colorectal carcinoma.
@en
Circulating and tumor-infiltra ...... nts with colorectal carcinoma.
@nl
P2093
P2860
P1433
P1476
Circulating and tumor-infiltra ...... nts with colorectal carcinoma.
@en
P2093
Huafeng Wei
Jianhua Ding
Liangliang Wu
Meng Zhang
Zhijun Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0057114
P407
P577
2013-02-20T00:00:00Z